Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit
ISTANBUL JOURNAL OF PHARMACY, vol.51, no.1, pp.1-7, 2021 (ESCI)
- Publication Type: Article / Article
- Volume: 51 Issue: 1
- Publication Date: 2021
- Doi Number: 10.26650/istanbuljpharm.2020.0041
- Journal Name: ISTANBUL JOURNAL OF PHARMACY
- Journal Indexes: Emerging Sources Citation Index (ESCI)
- Page Numbers: pp.1-7
- Open Archive Collection: AVESIS Open Access Collection
- Hacettepe University Affiliated: Yes
Abstract
Background and Aims: Many drugs with narrow therapeutic range and high toxicity risk are used in hematopoietic stem cell transplantation (HSCT) Units. The increase in the number of drugs raises the likelihood of interactions. This is particularly important in pediatric patients and may adversely affect the treatment process. In this study, we aimed to determine the potential drug interactions and to evaluate the clinical significance of them in terms of physician's and pharmacist's perceptions.